Minoxidil for women, read off the label and the trials

Minoxidil for women is the one route on this site with randomised, placebo-controlled trials in women behind it — and the one most often bought without anybody reading its label. So this page starts with the label, because it answers more of the questions people search for than any review does, and it is free.

Nothing here is a dose or a routine. Strengths are described exactly as they are printed on the product, and how to use anything is decided by the label you buy and the clinician you ask.

What the label says about time

The US Drug Facts label for the women's 5% foam, as published on DailyMed and updated 13 November 2024, gives the two dates people most want: it says under "when using this product" that it takes time to regrow hair and that "Results may occur at 3 months with once daily use", and under "stop use and ask a doctor" that you should do exactly that if "you do not see hair regrowth in 6 months".

Between those two marks sits the thing that frightens people out of the treatment early. The American Academy of Dermatology's page on female pattern hair loss says that for the first two to eight weeks you may notice a temporary increase in hair loss, and that an irritated scalp — dryness, scaling, itching, redness — is a common side effect. Neither of those is a secret the sellers keep; they are simply printed somewhere a product page does not repeat.

What the label says you should not do

The same label lists the situations in which the product is not to be used at all, and they are unusually specific for an over-the-counter box:

• your hair loss is sudden or patchy
• your hair loss followed childbirth
• you have no family history of hair loss
• you do not know the reason for your hair loss
• you are under 18
• your scalp is red, inflamed, infected, irritated or painful
• you are using other medicines on the scalp

It tells you to ask a doctor before use if you have heart disease, and to stop and ask a doctor if you get chest pain, a rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, swollen hands or feet, scalp irritation or redness, or unwanted facial hair growth.

On pregnancy and breastfeeding it is one sentence, and this site will not soften it or add to it: the label states that the product may be harmful if used when pregnant or breast-feeding. If that is your situation, the decision is a clinical one and it is not made on a website.

The label also has a household warning that surprises people: contact between children and minoxidil application sites should be avoided, because excessive hair growth has been reported in infants after skin contact with a caregiver's application site — reversible, the label says, within months of the exposure ending.

What the trials in women actually found

Two trials are worth knowing by name, because almost every claim made about minoxidil for women traces back to them.

The first is a 48-week randomised, double-blind, placebo-controlled multicentre trial of 381 women aged 18 to 49 with female pattern hair loss, published in the Journal of the American Academy of Dermatology in 2004. After 48 weeks, 5% topical minoxidil was superior to placebo on all three primary measures: the change in non-vellus hair count, the patient's own assessment of growth and scalp coverage, and the investigator's. The 2% solution beat placebo on hair count and the investigator's assessment, but the difference in what the women themselves reported was not significant. The 5% group also reported more itching, local irritation and unwanted hair growth than the 2% group or placebo.

The second is a 24-week randomised single-blind trial of 113 women, published in the same journal in 2011, comparing once-daily 5% foam with twice-daily 2% solution. The foam was non-inferior on hair count and hair width, and women using it reported significantly less itching and dandruff, and significantly more agreement that the treatment did not interfere with styling their hair.

Read together, those trials say something quite modest and quite useful: this works, in women, by a measurable amount, and the form you can live with daily matters as much as the strength on the box.

The same molecule in 560 different boxes

Minoxidil is not one product. On 24 September 2026, the US National Library of Medicine's DailyMed held 560 current minoxidil product listings from 228 different labelling companies, of which 53 carry the word "women" in the product name. The same active ingredient at the same strength appears under store brands, subscription brands, beard brands and brands invented last year.

That matters for two reasons. The cheerful one: the store-brand box is the same molecule as the advertised one, so the cheapest route to minoxidil is usually a pharmacy shelf, and it pays this site nothing. The less cheerful one: an over-the-counter monograph drug is not individually approved by the FDA before sale, so a crowded listing is not a quality ranking. The thing that tells you whether a given box is meant for you is the label on it — the strength, and the "do not use" list above.

Rogaine, and the box beside it

The label quoted throughout this page is the one filed for Women's Rogaine Unscented, because that is a current, specific, checkable women's product label on DailyMed — not because the brand is being recommended. Rogaine is one of the 228 companies with a minoxidil listing; the branded box and a store-brand box at the same strength contain the same active ingredient, and the Drug Facts panel on each tells you who the product is for.

What the brand buys you is a formulation you may find easier to live with — foam against solution is the difference the 113-woman trial actually measured — plus packaging and a price. What it does not buy you is a different molecule.

What happens if you stop

Minoxidil is a treatment, not a cure, and stopping it is a decision to accept the loss the treatment was holding back. Neither trial above followed women after withdrawal, so the honest version is the mechanism rather than a number: the hair that is being maintained by treatment is not being maintained once treatment ends.

This is the single most useful thing to weigh before starting, and it is rarely on the sales page: a treatment you will still be using in five years is a different purchase from one you will try for a season.

When minoxidil is the wrong answer entirely

Three situations come up constantly in searches, and in all three the label itself sends you elsewhere.

Hair loss after a birth. The label says not to use the product if the loss followed childbirth, and the dermatologists' own advice is that this usually resolves: shedding peaks about four months after giving birth and most women have their normal growth back by their child's first birthday. The timing, and what actually helps, is a separate piece.

Sudden or patchy loss. Also on the "do not use" list, and for good reason: patchy loss can be alopecia areata, and sudden or painful loss with scarring needs examining quickly, because scarring alopecias destroy follicles permanently.

Loss with no family history, or with other symptoms. Unexplained shedding with fatigue, weight change or cycle changes belongs in front of a clinician who can order tests, not in front of a checkout. The graded list of everything else offered to women starts from the same place, and so does every page here.

Oral minoxidil is a different medicine

Low-dose oral minoxidil is prescribed off-label for hair loss, and it is not a stronger version of the bottle. It is a blood-pressure tablet, taken by mouth, with its own contraindications, its own baseline checks and its own monitoring — all of which a 2025 international consensus statement in JAMA Dermatology spells out for prescribers rather than for readers. The panel of 43 specialists agreed 76 items and still said larger trials and standardised guidelines are lacking.

If a website offers it to you without a prescriber, that is the red flag, not the medicine. What women should know before that appointment is written for exactly that conversation.